| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.00B | $7.08B | $8.25B |
| YoY Revenue Growth % | -15.3% | -14.2% | — |
| Gross Profit | $1.98B | $3.22B | — |
| Gross Margin % | 33.1% | 45.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $84.2M | $1.77B | $2.54B |
| Operating Margin % | 1.4% | 25.0% | 30.8% |
| Net Income (GAAP) | $121.0M | $1.57B | $2.18B |
| EBITDA (Normalized) | $357.2M | $2.32B | $2.84B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.76B | $1.91B | $1.98B |
| Capital Expenditures (CapEx) | $341.2M | $694.0M | $371.4M |
| Free Cash Flow (FCF) | $1.42B | $1.21B | $1.61B |
| FCF Margin % | 23.7% | 17.1% | 19.5% |
| Return on Invested Capital (ROIC %) | 0.8% | 14.8% | 20.6% |
| Cash & Short-Term Equivalents | $2.15B | $2.69B | — |
| Total Debt (Short + Long Term) | $2.98B | $3.35B | $3.77B |
| Total Stockholders' Equity | $7.67B | $8.80B | $7.73B |